Q3 2024 Holdings
Filed 2024-11-14 | 119 holdings | $5.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $229.2K | 80,420 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $564.7K | 941,275 | 0.0% |
| C4 Therapeutics Inc(CCCC)Call | COM STK | 12529R107 | $855.0K | 150,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $1.5M | 1,927,000 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $1.5M | 448,891 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $1.6M | 1,141,200 | 0.0% |
| Turnstone Biologics Corp | COM | 90042W100 | $1.7M | 3,099,265 | 0.0% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $1.8M | 1,728,300 | 0.0% |
| Geron Corp(GERN)Call | COM | 374163103 | $1.8M | 400,000 | 0.0% |
| Biomx Inc | COM NEW | 09090D301 | $1.8M | 1,787,767 | 0.0% |
| Instil BIO Inc(TIL) | COM NEW | 45783C200 | $2.3M | 33,700 | 0.0% |
| Chemomab Therapeutics LTD | SPONSORED ADS | 16385C104 | $2.7M | 1,741,273 | 0.0% |
| Cassava Sciences Inc(SAVA)Put | COM | 14817C107 | $2.8M | 95,000 | 0.1% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $3.0M | 2,000,000 | 0.1% |
| Si-Bone Inc(SIBN)Call | COM | 825704109 | $3.5M | 250,000 | 0.1% |
| Traws Pharma Inc(TRAW) | COM NEW | 68232V884 | $3.6M | 605,531 | 0.1% |
| Ardent Health Partners Inc(ARDT) | COM | 03980N107 | $3.8M | 206,000 | 0.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $4.3M | 23,500 | 0.1% |
| Avidity Biosciences Inc(RNA)Call | COM | 05370A108 | $4.6M | 100,000 | 0.1% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $4.8M | 7,133,515 | 0.1% |
| Solventum Corp(SOLV)Call | COM SHS | 83444M101 | $4.8M | 69,300 | 0.1% |
| Tela BIO Inc(TELA) | COM | 872381108 | $5.5M | 2,161,185 | 0.1% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $5.7M | 170,000 | 0.1% |
| Inspiremd Inc(NSPR) | COM | 45779A846 | $5.7M | 2,133,405 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $5.9M | 1,680,580 | 0.1% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $5.9M | 742,300 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $6.1M | 570,300 | 0.1% |
| Ikena Oncology Inc | COM | 45175G108 | $6.1M | 3,539,358 | 0.1% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $6.2M | 50,000 | 0.1% |
| Moderna Inc(MRNA)Call | COM | 60770K107 | $6.7M | 100,000 | 0.1% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $6.7M | 1,480,600 | 0.1% |
| Pepgen Inc(PEPG) | COM | 713317105 | $6.8M | 797,358 | 0.1% |
| Passage BIO Inc | COM | 702712100 | $6.9M | 9,822,876 | 0.1% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $6.9M | 271,910 | 0.1% |
| Evolent Health Inc(EVH)Call | CL A | 30050B101 | $7.3M | 258,400 | 0.1% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $7.5M | 351,618 | 0.1% |
| Lyell Immunopharma Inc | COM | 55083R104 | $8.4M | 6,086,001 | 0.2% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $8.6M | 2,862,448 | 0.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $9.2M | 967,000 | 0.2% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $9.6M | 6,475,291 | 0.2% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $10.9M | 4,180,768 | 0.2% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $11.4M | 3,322,488 | 0.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $11.8M | 764,600 | 0.2% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $12.2M | 103,000 | 0.2% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $12.7M | 151,700 | 0.2% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $14.3M | 4,533,801 | 0.3% |
| Medpace Hldgs Inc(MEDP) | COM | 58506Q109 | $15.0M | 44,900 | 0.3% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $16.5M | 11,447,140 | 0.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $16.8M | 383,705 | 0.3% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $17.3M | 11,024,000 | 0.3% |